Health Affairs March 30, 2020
Public health response to an emerging infectious disease creates demands for preventive, diagnostic, and therapeutic interventions. As the COVID-19 pandemic has unfolded, concerns about the cost and availability of a potential vaccine have emerged.
While this concern is understandable given the current public health crisis and ongoing concern about patient affordability of health care generally, safeguards for vaccine access and a vaccine procurement and distribution infrastructure are already in place. A range of existing policies and programs promote widespread, affordable access to marketed vaccines, as well as public-private partnerships to support the development and potential stockpiling of new vaccines that address threats like COVID-19.
As the country grapples with the challenges presented by the coronavirus, policymakers should remain mindful...
Today's Sponsors
Today's Sponsor